
Nelson Dusetti
Mar 25, 2025, 11:05
Nelson Dusetti: PANCprofiler – A step forward in personalizing pancreatic cancer treatment
Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research Centre of Marseille (CRCM), shared a post on LinkedIn:
“A step forward in personalizing pancreatic cancer treatment!
We were honored to present our latest work at JFHODs, where we unveiled for the first time the development of PANCprofiler, an innovative transcriptomic signature based on deconvolution, designed to detect multidrug-resistant cells within pancreatic tumors.
A great achievement by Nicolas Fraunhoffer and the Marseille Pancreatic Cancer Team!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 25, 2025, 11:04
Mar 25, 2025, 10:22
Mar 25, 2025, 10:19
Mar 25, 2025, 09:54